Basil Michelle L 4

What Happened

• Michelle L. Basil, EVP and General Counsel of Haemonetics (HAE), was granted 28,424 restricted stock units (RSUs) on May 15, 2026 and, in connection with RSU vesting tax obligations, had 2,913 shares withheld (disposed) at $56.29 per share for $163,973.
• The withheld shares reflect tax withholding (transaction code F), not an open-market sale. The RSU award (transaction code A) has no immediate cash value until the units vest.

Key Details

• Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (filed within the standard 2-business-day window).
• Withheld/disposed: 2,913 shares at $56.29 each, total $163,973 (tax withholding).
• Award/acquired: 28,424 RSUs (no per-share price reported for RSUs).
• Vesting and plan details: RSUs issued under the Haemonetics Amended and Restated 2019 Long-Term Incentive Compensation Plan; vest 40% on year 1, 40% on year 2, 20% on year 3. Each RSU converts to one share upon vesting.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: withholding represents shares used to satisfy tax obligations; award includes unvested RSUs previously reported.

Context

• RSU grants are compensation and vest over time; they do not indicate an immediate purchase or sale by the insider until vested and/or sold.
• The withheld shares were a routine tax-related disposition (code F), not a directional bet on the stock.